StockData
AgomAb Therapeutics NV logo

AgomAb Therapeutics NV (AGMB) SEC filings

AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 23, 2026Score 2/30
$5.97−0.39 (-6.13%)

Close on Nov 16, 2026Market cap $149.25KP/E –Yield –

SEC filings

12 of AgomAb Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report6-KOct 13, 2026Oct 13, 2026SEC EDGAR
Current report6-KOct 1, 2026Oct 1, 2026SEC EDGAR
Current report6-KSep 14, 2026Sep 14, 2026SEC EDGAR
Current report6-KSep 11, 2026Sep 11, 2026SEC EDGAR
Current report6-KAug 10, 2026Aug 10, 2026SEC EDGAR
Current report6-KAug 6, 2026Aug 6, 2026SEC EDGAR
Current report6-KJun 23, 2026Jun 23, 2026SEC EDGAR
Current report6-KMay 27, 2026May 27, 2026SEC EDGAR
Current report6-KApr 24, 2026Apr 24, 2026SEC EDGAR
Annual report20-FDec 31, 2025Apr 23, 2026SEC EDGAR
Current report6-KMar 5, 2026Mar 5, 2026SEC EDGAR
Current report6-KFeb 9, 2026Feb 9, 2026SEC EDGAR

See a number that looks wrong?